Close Menu

NEW YORK – Aethlon Medical announced on Monday that it has received a $1.9 million award from the National Cancer Institute.

The two-year, Small Business Innovation Research (SBIR) Phase 2 contract will fund development and optimization of Aethlon's Hemopurifier, a benchtop device that isolates exosomes from biofluids for applications in cancer research and clinical care.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.